ArticleBMC cancer2023

Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study.

Haohao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.